United Kingdom

Shin Nippon Biomedical Laboratories Ltd (2395.T)

2395.T on Tokyo Stock Exchange

17 Sep 2019
Change (% chg)

¥22 (+3.14%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Ryoichi Nagata

57 2016 Chairman of the Board, President, Group Chief Executive Officer, Chairman of Subsidiary, Representative Director

Koichiro Fukuzaki

57 2016 Vice Chairman of the Board

Takeshi Yamakawa

49 2011 Chief Executive Officer of Subsidiary, Director

Ken Takanashi

54 2017 Chief Operating Officer, Vice President, Representative Director

Shuichi Kanazashi

2014 Managing Director, President of TR Business Company